Skip to content

Clinical trials

Phase 1 Lymphoma, Large B-Cell, Diffuse trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large B-Cell, Diffuse Phase: Phase 1 Country / region: China Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20151
20163
20183
20192
20206
20225
20236
20242
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status11
Recruiting8
Completed7
Terminated5
Not yet recruiting3
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Second Affiliated Hospital, Zhejiang University, School of Medicine3
He Huang2
Institute of Hematology & Blood Diseases Hospital, China2
Novartis Pharmaceuticals2
The First Affiliated Hospital with Nanjing Medical University2
Anhui Provincial Hospital1
Antengene Corporation1
Ascentage Pharma Group Inc.1
BeBetter Med Inc1
BeOne Medicines1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large B-Cell, Diffuse36
Lymphoma, Follicular11
Lymphoma, Mantle-Cell9
Lymphoma, B-Cell, Marginal Zone6
Lymphoma, B-Cell4
Lymphoma, Non-Hodgkin4
Leukemia, Lymphocytic, Chronic, B-Cell3
Recurrence2
Bronchiolitis Obliterans Syndrome1
Burkitt Lymphoma1

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.